Press Releases Year All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Feb 04, 2021 TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors Jan 19, 2021 TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock Jan 19, 2021 TCR² Therapeutics Announces Proposed Public Offering of Common Stock Jan 08, 2021 TCR² Therapeutics Announces 2021 Strategic Priorities and Milestones Pagination First page « first Previous page ‹ previous Page 1 Current page 2
